Inside story of Kodak's surge on $765m White House loan to pivot into drugs

Loading player...
Mostly forgotten photography icon Eastman Kodak jumped into the headlines this month after the Trump White House picked it out for special treatment in a plan to move production of chemicals that go into cornavirus drugs back to the US. The now tiny US company was incentivised through a $765m government loan - news of which sent its share price from $2 to over $60 before easing back to close the session at $33 and ease back further to its current $10, still five times the pre-loan announcement. Here's the inside story from our partners at the Wall Street Journal. Learn more about your ad choices. Visit megaphone.fm/adchoices
11 Aug 2020 10AM English South Africa Investing · Business News

Other recent episodes

BN Edge | Piet le Roux: ICASA, Starlink and the true cost of BEE

To sell internet access in South Africa, you first have to show ICASA the race of your shareholders. Sakeliga has now taken the regulator to the Pretoria High Court, but, oddly, not to scrap the 30% black-ownership rule. Chief executive Piet le Roux told Alec Hogg why he chose the…
13 Nov 6AM 28 min